f Translational Informatics for Neuropharmacology: Databases, Ontologies, and Analytics

References

1. Zheng X. Chen J. Zhang Y. Hu S. Bi C. Singla R. K. Kamal M.A. Horimoto K. Shen B. Translational informatics driven drug repositioning for neurodegenerative disease. Curr Neuropharmacol 2025 23 0 000 000 10.2174/011570159X327908241121062335 39936420
   [Google Scholar]
2. Shen B. Lin Y. Bi C. Zhou S. Bai Z. Zheng G. Zhou J. Translational informatics for Parkinson’s disease: From big biomedical data to small actionable alterations. Genom Proteom Bioinform 2019 17 4 415 429 10.1016/j.gpb.2018.10.007 31786313
   [Google Scholar]
3. Yu C. Zong H. Chen Y. Zhou Y. Liu X. Lin Y. Li J. Zheng X. Min H. Shen B. PCAO2: an ontology for integration of prostate cancer associated genotypic, phenotypic and lifestyle data. Brief. Bioinform. 2024 25 3 bbae136 10.1093/bib/bbae136 38557678
   [Google Scholar]
4. Yang H. Li J. Zhang C. Sierra A.P. Shen B. Large language model–driven knowledge graph construction in sepsis care using multicenter clinical databases: Development and usability study. J. Med. Internet Res. 2025 27 e65537 10.2196/65537 40146985
   [Google Scholar]
5. Tinazzi M. Gandolfi M. Artusi C.A. Bannister K. Rukavina K. Brefel-Courbon C. de Andrade D.C. Perez-Lloret S. Mylius V. Advances in diagnosis, classification, and management of pain in Parkinson’s disease. Lancet Neurol. 2025 24 4 331 347 10.1016/S1474‑4422(25)00033‑X 40120617
   [Google Scholar]
6. Cantor M.N. Translational informatics: An industry perspective. J. Am. Med. Inform. Assoc. 2012 19 2 153 155 10.1136/amiajnl‑2011‑000588 22237867
   [Google Scholar]
7. Mittal P. Gautam R.K. Sharma H. Goyal R. Neural networks of knowledge: Ontologies pioneering precision medicine in neurodegenerative diseases. Curr. Neuropharmacol. 2025 23 0 000 000
   [Google Scholar]
8. Bernal-Vicente B.N. Ponce I. Santos-Gutiérrez M. Neuroprotective proteins in hypoxia-stressed astrocyte-derived extracellular vesicles. Curr. Neuropharmacol. 2025 23 0 000 000
   [Google Scholar]
9. Ahmad S. Wang L. Zafar I. Abbas Z. Unar A. Mohany M. Al-Rejaie S.S. Ullah Khan N. Ali I. Shafiq M. Informatics approach towards targeting HTR1B pathways in neuropharmacology for migraine treatment. Curr. Neuropharmacol. 2025 23 0 000 000 10.2174/011570159X341703250130064735 39936416
   [Google Scholar]
10. Glotfelty E.J. Karlsson T.E. Tovar-y-Romo L.B. Olson L. Harvey B.K. Greig N.H. Analyses of Nogo-family genes in mouse and human microglia omics datasets identify LINGO1 as a candidate drug target in Alzheimer’s Disease. Curr. Neuropharmacol. 2025 23 0 000 000
    [Google Scholar]
11. Batool Z. Hu S.S. Kamal M.A. Greig N.H. Shen B. Advancing Alzheimer’s diagnosis with AI-enhanced MRI: A review of challenges and implications. Curr. Neuropharmacol. 2025 23 0 000 000
    [Google Scholar]
12. Khan K.A. Esa M. Kamal Z. Ullah B. Perry G. Kamal S. Ahmad S. Hussain H. Ullah A. Shafique M. Conventional and emerging drug targeting sites in Alzheimer’s disease and the role of translational informatics in its diagnosis and management. Curr. Neuropharmacol. 2025 23 0 000 000 10.2174/011570159X361867250313073624 40207764
    [Google Scholar]
13. Muzaffer U. Gull B. Ahmed Z. Ahmad M. Neuropharmacological interventions of plant origin for Parkinson’s disease: A comprehensive appraisal. Curr. Neuropharmacol. 2025 23 0 000 000
    [Google Scholar]